About Fjellmark

About

Fjellmark is an independent information resource. Our mission is to offer clear, evidence-first information on ibogaine’s legal status, health risks, and access considerations in Norway. We present vetted material so readers can distinguish established facts from uncertain or misleading claims.

Close-up detail view related to legal and safety information about ibogaine in Norway, photographed as a cropped editorial detail.

Our editorial approach

We compile guidance, regulatory notices, peer-reviewed literature, and public health materials to produce concise, unbiased summaries. Our editorial process favours primary sources where possible and uses registries and official documents to verify claims before publication.

For transparency we include links to source documents and to organisations when statements rely on specific regulations; for example, our work cites government and registry material that explain legal standing and oversight in other jurisdictions (see an explanatory overview on health policy fundamentals on Wikipedia to understand the types of sources we consult).

How we verify

Verification is a mix of primary-document review, cross-checking with trusted academic repositories and public health advisories, and conservative editorial judgment. We rely on established repositories (including academic .edu pages and official public health sites) when available; for example, high-level methodology guidance from academic institutions helps shape how evidence is assessed (NIH).

Navigation and structure

Material is organised for fast scanning: concise summaries up front, followed by a snapshot of key workflows and links to deeper sections. To revisit context quickly, readers can follow in-text links that direct to topical pages such as our services overview or the topical legal summary that explains jurisdictional issues in Norway.

Editorial principles

We follow a compact set of guiding practices to keep the site trustworthy and useful.

  • Independence — we do not operate as a clinic or treatment provider.
  • Evidence-before-hype — claims are supported by primary documents where possible.
  • Plain language — technical detail is summarised for non-specialist readers.
  • Transparency — we cite sources and correct errors openly when discovered.

Why does Fjellmark exist?

Fjellmark exists to provide clear, concise information about the legal and safety dimensions of ibogaine in a Norwegian context. We aim to reduce confusion by separating evidence-based material from speculation, and to direct readers to authoritative sources when appropriate.

How should readers use this site?

Use Fjellmark as an informational starting point: a concise digest of laws, public health notices, and safety considerations. For individual clinical decisions, readers should consult licensed health professionals or regulators and not rely solely on our summaries. For examples of regulatory resources we consult, see official public health pages such as Norwegian Institute of Public Health.

Can I rely on Fjellmark for legal or medical advice?

No. Fjellmark is explicitly an independent information resource and not a clinic, medical provider, or licensed treatment centre. Content is educational and should not be interpreted as personalised medical or legal advice.

How can I see related offerings?

We keep a compact services overview that describes the kinds of editorial and research support we provide; that overview is available on our services page, and our homepage links collect topical entries for quick reference (for instance, some summaries reference external treatment directories like the one maintained by independent European networks at Ibogaine Treatment Europe when relevant).

Independent by design

We are intentionally neutral and transparent about our limits. Fjellmark does not operate as a clinic or provider; our role is to inform. If you need medical or legal advice, please contact an appropriately licensed professional. To revisit our site hub, return to the main overview at Fjellmark’s homepage.

Our mission: Fjellmark offers clear, evidence-first information on ibogaine’s legal status, health risks, and access considerations in Norway.